Taltz (ixekizumab)
pCPA File Number:
21192
Negotiation Status:
Under consideration for negotiation
Indication(s):
Ankylosing spondylitis
Sponsor/Manufacturer:
Eli Lilly Canada Inc.
CADTH Project Number:
SR0630-000
pCPA Engagement Letter Issued:
Not Applicable
Negotiation Process Concluded:
Not Applicable